About ASN

Prabir Roy-Chaudhury, MD, PhD, FASN

ASN Biography

Prabir Roy-Chaudhury MD, PhD, FRCP (Edin) is a Professor of Medicine and the Division Director for Nephrology at the University of Arizona. He is also the Director of the Arizona Kidney and Vascular Center. After graduating from the Armed Forces Medical College, Pune, India, he trained in Internal Medicine and Nephrology at the University of Aberdeen, Scotland and at the Beth Israel Hospital, Harvard Medical School, Boston, USA. In addition to being an active transplant nephrologist, Dr. Roy-Chaudhury’s main research interest is in dialysis vascular access and uremic vascular disease and while at the University of Cincinnati (for over 15 years), he directed the Dialysis Vascular Access Research Program which was a comprehensive, integrated, multi-disciplinary translational research program, which included basic science, clinical science and patient care components. This translational research program was funded through the National Institutes of Health, the Veterans Administration research program and through industry grants. Dr. Roy-Chaudhury has received national and international awards, has published over 150 peer reviewed manuscripts and is a sought after invited speaker, both nationally and internationally.

Dr. Roy-Chaudhury has also been actively involved in the public policy and administrative aspects of dialysis vascular access care and hemodialysis as a board member/councilor/committee chair for the American Society of Diagnostic and Interventional Nephrology, the Renal Network, the Interventional Nephrology Advisory Group of the American Society of Nephrology (ASN), the Cincinnati chapter of the National Kidney Foundation and the Medical Advisory Board of the Life Center (Ohio). He is a member of the ASN Board of Advisors and a member of the ASN Postgraduation Education Committee. Dr. Roy-Chaudhury is also the American Society of Nephrology co-chair of the Kidney Health Initiative which is a public-private partnership between the ASN and the FDA which aims to bring together nephrologists, industry partners, patient advocacy groups and regulatory agencies; in an attempt to facilitate the passage of drugs, devices and biologics into the kidney disease space.

Dr. Roy-Chaudhury is the American Society of Nephrology Co-Chair on the KHI Board of Directors.